GILD

← Markets

GILDGilead Sciences, Inc.

+0.50

Signal

Stories2

Sources2

Heat-0.4

Discussion

Nothing said here yet.

to join the conversation.


WELTERS ANTHONYDirector	Sell	6,880	$1.0M	Wed, Aug 26
WELTERS ANTHONYDirector	Sell	4,600	$684.6K	Wed, Aug 26
WELTERS ANTHONYDirector	Sell	3,402	$504.3K	Wed, Aug 26
WELTERS ANTHONYDirector	Sell	3,118	$462.4K	Wed, Aug 26
Bluestone JeffreyDirector	Sell	1,816	$263.2K	Thu, Aug 20
Bluestone JeffreyDirector	Sell	1,658	$241.6K	Thu, Aug 20
Bluestone JeffreyDirector	Sell	1,165	$167.5K	Thu, Aug 20
Bluestone JeffreyDirector	Sell	335	$49.0K	Thu, Aug 20
Bluestone JeffreyDirector	Sell	26	$3.8K	Thu, Aug 20
Mercier JohannaChief Comm & Corp Aff Officer	Sell	16,530	$2.3M	Mon, Aug 17
Mercier JohannaChief Comm & Corp Aff Officer	Sell	11,470	$1.6M	Mon, Aug 17
Dickinson Andrew DChief Financial Officer	Sell	3,000	$415.1K	Mon, Aug 17

WELTERS ANTHONYDirector

Sell

6,880

$1.0M

Wed, Aug 26

WELTERS ANTHONYDirector

Sell

4,600

$684.6K

Wed, Aug 26

WELTERS ANTHONYDirector

Sell

3,402

$504.3K

Wed, Aug 26

WELTERS ANTHONYDirector

Sell

3,118

$462.4K

Wed, Aug 26

Bluestone JeffreyDirector

Sell

1,816

$263.2K

Thu, Aug 20

Bluestone JeffreyDirector

Sell

1,658

$241.6K

Thu, Aug 20

Bluestone JeffreyDirector

Sell

1,165

$167.5K

Thu, Aug 20

Bluestone JeffreyDirector

Sell

335

$49.0K

Thu, Aug 20

Bluestone JeffreyDirector

Sell

$3.8K

Thu, Aug 20

Mercier JohannaChief Comm & Corp Aff Officer

Sell

16,530

$2.3M

Mon, Aug 17

Mercier JohannaChief Comm & Corp Aff Officer

Sell

11,470

$1.6M

Mon, Aug 17

Dickinson Andrew DChief Financial Officer

Sell

3,000

$415.1K

Mon, Aug 17


Thomas H Tubervilleoptions	Buy	$24.0K	Fri, May 10	Wed, Aug 5
Thomas H Tuberville	Sell	$8.0K	Wed, May 8	Wed, Aug 5
Alan Armstrong	Buy	$8.0K	Fri, Mar 27	Tue, Jul 21
Jared Moskowitz	Buy	$8.0K	Wed, May 6	Sun, May 31

Thomas H Tubervilleoptions

Buy

$24.0K

Fri, May 10

Wed, Aug 5

Thomas H Tuberville

Sell

$8.0K

Wed, May 8

Wed, Aug 5

Alan Armstrong

Buy

$8.0K

Fri, Mar 27

Tue, Jul 21

Jared Moskowitz

Buy

$8.0K

Wed, May 6

Sun, May 31

Fri, Aug 28
9:41 AMYahooGilead Wins FDA Nod for Bixlenvo in Adults Living With HIV Infection
9:26 AMCNBC WorldFDA approves daily HIV pill from Gilead designed to simplify treatment for some patients
8:02 AMSeeking Alpha4 stocks to watch on Friday: MRNA, GILD, JBLU, and LLY
6:41 AMSeeking AlphaGilead once-daily HIV pill approved in U.S.
Thu, Aug 27
5:15 PMYahooGilead (GILD) Stock Looks Undervalued After A 147% Five Year Run
4:47 PMstocktitan.netU.S. FDA Approves Gilead’s Bixlenvo™, a New Once-Daily Single Tablet Option for Virologically Suppressed Adults With HIV, Including Those on Complex Regimens
7:14 AMYahooGilead Sciences (GILD) Wins EU Trodelvy Approval, Is The Stock Fully Priced?
3:15 AMYahooWhat Does Gilead Sciences (GILD) Gain From Its Expanded EU Breast Cancer Approval?
Wed, Aug 26
3:05 PMstocktitan.netGilead Sciences to Present at Upcoming Third Quarter 2026 Investor Conferences
8:50 AMYahooGilead Sciences Has Snapped Out of Its Slump -- and 1 Catalyst Is Doing Most of the Heavy Lifting
Mon, Aug 24
3:04 PMstocktwits.comGILD Stock Garners Retail Attention On Trodelvy EU Approval Ahead Of August 27 HIV FDA Verdict
6:21 AMSeeking AlphaEU approves Gilead’s Trodelvy combination with Keytruda for first-line breast cancer